Literature DB >> 10690585

Complications of inflammatory bowel disease.

C Gasche1.   

Abstract

Complications in inflammatory bowel disease determine the severity of disease as well as the complexities of medical or surgical treatment opportunities. Therefore, in known inflammatory bowel disease, the prevention, the early detection and the adequate therapeutic response to certain complications are important goals in the follow-up of inflammatory bowel disease patients. Disease complications are separated into intestinal and extraintestinal complications. Intestinal complications are somewhat disease specific, which means that they occur exclusively in either Crohn's disease or ulcerative colitis (e.g., enteric fistulas are particularly found in Crohn's disease and toxic megacolon in ulcerative colitis). Most extraintestinal complications occur in both forms of inflammatory bowel disease (e.g., anemia, thromboembolic events or osteoporosis). The current knowledge on pathogenesis, diagnostic tools, prevention and treatment of certain intestinal and extraintestinal complications is reviewed.

Entities:  

Mesh:

Year:  2000        PMID: 10690585

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  11 in total

Review 1.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

Review 2.  [Iron deficiency : Recognition and treatment].

Authors:  S von Haehling; H Ottenjann; S D Anker
Journal:  Internist (Berl)       Date:  2017-06       Impact factor: 0.743

3.  Improving Anemia in Inflammatory Bowel Disease: Impact of the Anemia Care Pathway.

Authors:  Talha Qureshi; T Peter Nguyen; Ruifei Wang; Diana Willis; Rajesh Shah; Jason K Hou
Journal:  Dig Dis Sci       Date:  2019-03-16       Impact factor: 3.199

4.  Haemoglobin levels are associated with bone mineral density in the elderly: a population-based study.

Authors:  Alice Laudisio; Emanuele Marzetti; Francesco Pagano; Roberto Bernabei; Giuseppe Zuccalà
Journal:  Clin Rheumatol       Date:  2008-09-03       Impact factor: 2.980

Review 5.  Treatment of anemia in inflammatory bowel disease--systematic review and meta-analysis.

Authors:  Tomer Avni; Amir Bieber; Tali Steinmetz; Leonard Leibovici; Anat Gafter-Gvili
Journal:  PLoS One       Date:  2013-12-02       Impact factor: 3.240

6.  Association between Hemoglobin Level and Bone Mineral Density in Korean Adults.

Authors:  Yun Hwan Oh; Ji Hyun Moon; Belong Cho
Journal:  J Bone Metab       Date:  2017-08-31

7.  Bone Mineral Density and Hemoglobin Levels: Opposite Associations in Younger and Older Women.

Authors:  Tzyy-Ling Chuang; Malcolm Koo; Mei-Hua Chuang; Yuh-Feng Wang
Journal:  Int J Environ Res Public Health       Date:  2021-05-20       Impact factor: 3.390

8.  A randomized, open-label, non-inferiority study of intravenous iron isomaltoside 1,000 (Monofer) compared with oral iron for treatment of anemia in IBD (PROCEED).

Authors:  Walter Reinisch; Michael Staun; Rakesh K Tandon; Istvan Altorjay; Andrew V Thillainayagam; Cornelia Gratzer; Sandeep Nijhawan; Lars L Thomsen
Journal:  Am J Gastroenterol       Date:  2013-10-22       Impact factor: 10.864

9.  Perioperative use of immunosuppressive medications in patients with Crohn's disease in the new "biological era".

Authors:  Amy L Lightner; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2017-04-07

10.  Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK.

Authors:  Aysegül Aksan; Ian L P Beales; Garth Baxter; Antonio Ramirez de Arellano; Simona Gavata; William J Valentine; Barnaby Hunt
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.